In an analysis of the Scottish Care Information Diabetes registry, which included observational data from 248,400 patients with diabetes, the use of GLP-1 RAs and SGLT2is was low, irrespective of the patients history of CVD [74]
This was a landmark result that positioned semaglutide as the first obesity medication with proven heart protection
Moreover, semaglutide has been shown to be highly effective for treating obesity, even in the absence of diabetes, providing a powerful tool for weight management and overall health improvement
PubMed laboratory research record [PMID: 19097513] PubMed record related to this compound for laboratory literature review
Read our Latest Blogs L Carnitine Benefits | How Much L Carnitine Per Day | L Carnitine Dosage | L Carnitine Fat Burner | L Carnitine Natural Sources | L Carnitine Pre Workout | Does L Carnitine Work | Does L Carnitine Burn Fat | L Carnitine Liquid Benefits Frequently Asked Questions Q1: How much L-Carnitine should I take daily for fat loss